A rare blood disorder and life-saving treatment costing more than R6-million a year reveals the harsh financial choices facing medical aid schemes.
This summary is based on reporting by Daily Maverick.
Press Enter to search — Esc to close
A rare blood disorder and life-saving treatment costing more than R6-million a year reveals the harsh financial choices facing medical aid schemes.
A rare blood disorder and life-saving treatment costing more than R6-million a year reveals the harsh financial choices facing medical aid schemes.
This summary is based on reporting by Daily Maverick.
Please Accept Cookies for Better Performance